Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xiaoyu Jiangzhi capsule in chronic coronary syndrome (inflammation and lipids)
ChiCTR2600121740Phase 4Recruiting
- Sponsor
- Shanghai East Hospital
- Start
- Apr 2026
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Xiaoyu Jiangzhi capsule in Chronic Coronary Syndrome (CCS) (2 arms), sponsored by Shanghai East Hospital. Primary endpoint: hs-CRP at week 12. Started Apr 2026; status: recruiting.
02
Drugs
Xiaoyu Jiangzhi capsule
03
Conditions
Chronic Coronary Syndrome (CCS)
Beyond the preview
Go deeper on ChiCTR2600121740.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600121740.